Ensayos clínicos
PYRUVATE KINASE DEFICIENCY GLOBAL LONGITUDINAL REGISTRY (AG348-C-008 OBS DPK)
PYRUVATE KINASE DEFICIENCY GLOBAL LONGITUDINAL REGISTRY (AG348-C-008 OBS DPK)
Centros: Hospital Universitario Vall de Hebrón (Barcelona), Hospital Universitario La Paz (Madrid), H. Sant Joan de Déu (Barcelona), H. de la Santa Creu i Sant Pau (Barcelona)
Contacto: Dr. David Beneitez (H. Vall de Hebrón), Dra. Marta Morado (H.Universitario La Paz)
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AG-348 IN NOT REGULARLY TRANSFUSED ADULT SUBJECTS WITH PYRUVATE KINASE DEFICIENCY (AG348-C-006 F III DPK)
AN OPEN-LABEL, MULTICENTER, EXTENSION STUDY OF AG-348 IN ADULT SUBJECTS WITH PYRUVATE KINASE DEFICIENCY PREVIOUSLY ENROLLED IN AG-348 STUDIES (AG348-C-011 FIII EXTENSIÓN DPK)
LENTIVIRAL-MEDIATED GENE THERAPY OF FANCONI ANEMIA PATIENTS SUBTYPE A (FANCOLEN-1)
PARICALCITOL IMPROVES ANEMIA OF INFLAMATION (PIERAID)
USEFULNESS OF FECAL IMMUNOCHEMICAL TEST IN IRON DEFICIENCY ANEMIA (IDAFIT) (IDAFIT)
EFFECTS OF IRON THERAPY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION AND IRON DEFICIENCY (PREFER-HF) (PREFER-HF)
ELTROMBOPAG COMBINED WITH CYCLOSPORINE AS FIRST LINE THERAPY IN PATIENTS WITH SEVERE ACQUIRED APLASTIC ANEMIA (SOAR)
EFFICACY AND SAFETY OF FG-4592 FOR TREATMENT OF ANEMIA IN PATIENTS WITH LOWER RISK MDS WITH LOW RED BLOOD CELL TRANSFUSION BURDEN
EFFICACY AND SAFETY STUDY OF LUSPATERCEPT (ACE-536) VERSUS EPOETIN ALFA FOR THE TREATMENT OF ANEMIA DUE TO IPSS-R VERY LOW, LOW OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES (MDS) IN ESA NAÏVE SUBJECTS WHO REQUIRE RED BLOOD CELL TRANSFUSIONS (COMMANDS)